Linked Life Data

17455762

Source:http://linkedlifedata.com/resource/pubmed/id/17455762

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 1
pubmed:dateCreated
2007-4-25
pubmed:abstractText
Given the increasing commercial and clinical relevance of probiotic cultures, improving their stress tolerance profile and ability to overcome the physiochemical defences of the host is an important biological goal. Pathogenic bacteria have evolved sophisticated strategies to overcome host defences, interact with the immune system and interfere with essential host systems. We coin the term 'patho-biotechnology' to describe the exploitation of these valuable traits in biotechnology and biomedicine. This approach shows promise for the design of more technologically robust and effective probiotic cultures with improved biotechnological and clinical applications as well as the development of novel vaccine and drug delivery platforms.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0036-8504
pubmed:author
pubmed:issnType
Print
pubmed:volume
90
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-14
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Patho-biotechnology; using bad bugs to make good bugs better.
pubmed:affiliation
Alimentary Pharmabiotic Centre, Cork, Ireland. R.Sleator@ucc.ie
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't